Brief: The Oncology Institute Reaffirms 2025 Guidance And Provides Preliminary 2026 Outlook
Jan 12 (Reuters) - Oncology Institute Inc TOI.O: THE ONCOLOGY INSTITUTE REAFFIRMS 2025 GUIDANCE AND PROVIDES PRELIMINARY 2026 OUTLOOK ONCOLOGY INSTITUTE INC - ANTICIPATES 2026 REVENUE BETWEEN $630 MILLION AND $650 MILLION ONCOLOGY INSTITUTE INC: LOOKING BEYOND 2026, CO IS WELL POSITIONED FOR CONTINUED EXPANSION Source text: ID:nGNXbXwg8q Further company coverage: TOI.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Starling Oncology
See all newsBrief: Starling Oncology Unit Enters Credit Agreement On August 20
Brief: Starling Oncology Q2 EPS USD -0.08
Brief: Oncology Institute Rebrands As Starling Oncology
Oncology Institute Q1 revenue rises on specialty pharmacy growth, reaffirms 2026 revenue guidance
Brief: Oncology Institute Q1 Gross Profit USD 23.3 Million